Giannelos, Nikolaos http://orcid.org/0000-0001-9130-4744
Curran, Desmond http://orcid.org/0000-0002-7423-0111
Nguyen, Chi
Kagia, Carol http://orcid.org/0000-0003-3029-6642
Vroom, Nikki http://orcid.org/0000-0002-4571-5291
Vroling, Hilde http://orcid.org/0000-0002-5840-3676
Funding for this research was provided by:
GlaxoSmithKline Biologicals SA
Article History
Received: 5 April 2024
Accepted: 30 May 2024
First Online: 19 June 2024
Declarations
:
: Nikolaos Giannelos and Desmond Curran are employed by and hold financial equities in GSK. The authors declare no other financial or non-financial relationships and activities. Carol Kagia, Chi Nguyen, Hilde Vroling and Nikki Vroom are employees of P95/Pallas. P95/Pallas received funding from GSK for the submitted work. P95/Pallas holds/held contracts with AstraZeneca, CEPI, GSK, Pfizer, Sanofi, Seqirus, Orchard, Biomarin, Daiichi, Bavarian Nordic and Bayer. Authors declare no other financial and non-financial relationships and activities.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. Due to this reason an ethics committee approval was not required.